IGF2BP1 was a miR-708 target, and overexpression of IGF2BP1 restored cisplatin resistance by promoting Akt phosphorylation in miR-708-overexpressing ovarian cancer cells [39]. Here, IGF2BP1 is linked to ovarian carcinoma.